Trupanion, Inc. (NASDAQ: TRUP) is a Financial Services company in the Insurance - Property & Casualty industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
25.63
+0.00%
TA
Loading chart...
Snapshot
| Index | - | P/E | 48.36 | EPS (ttm) | 0.53 | Insider Own | 5.40% | Shs Outstand | 43.62M | Perf Week | 2.52% |
| Market Cap | 1.12B | Forward P/E | 36.99 | EPS next Y | 0.69 | Insider Trans | -1.31% | Shs Float | 33.26M | Perf Month | -14.48% |
| Enterprise Value | 826.99M | PEG | - | EPS next Q | 0.16 | Inst Own | - | Short Float | 12.01% | Perf Quarter | 8.74% |
| Income | 24.00M | P/S | 0.74 | EPS this Y | 18.15% | Inst Trans | - | Short Ratio | 8.89 | Perf Half Y | -0.19% |
| Sales | 1.52B | P/B | 2.73 | EPS next Y | 10.65% | ROA | 2.49% | Short Interest | 3.99M | Perf YTD | -31.42% |
| Book/sh | 9.40 | P/C | 2.81 | EPS next 5Y | -2.04% | ROE | 5.96% | 52W High | 46.98 -45.44% | Perf Year | -42.37% |
| Cash/sh | 9.12 | P/FCF | 13.21 | EPS past 3/5Y | - | ROIC | 4.29% | 52W Low | 21.16 21.12% | Perf 3Y | -6.36% |
| Dividend Est. | - | EV/EBITDA | 15.90 | Sales past 3/5Y | 16.72% 23.44% | Gross Margin | 22.48% | Volatility | 3.82% 3.93% | Perf 5Y | -71.85% |
| Dividend TTM | - | EV/Sales | 0.54 | EPS Y/Y TTM | 330.43% | Oper. Margin | 1.61% | ATR (14) | 1.24 | Perf 10Y | 67.63% |
| Dividend Ex-Date | - | Quick Ratio | 1.85 | Sales Y/Y TTM | 18.27% | Profit Margin | 1.53% | RSI (14) | 40.40 | Recom | 2.47 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.77 | EPS Q/Q | -27.27% | SMA20 | -8.67% | Beta | 1.43 | Target Price | 34.25 |
| Payout | 0.00% | Debt/Eq | 0.29 | Sales Q/Q | 11.02% | SMA50 | -6.19% | Rel Volume | 0.87 | Prev Close | 25.63 |
| Employees | 1,121 | LT Debt/Eq | 0.27 | Earnings | Nov 05 | SMA200 | -9.20% | Avg Volume | 454.69K | Price | 25.63 |
| IPO Date | Jul 18, 2014 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 41.18% 0.82% | Net Debt/EBITDA | -0.81 | Volume | 394,980 | Change | 0.00% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-26-26 | Downgrade | Piper Sandler | Overweight → Neutral | $45 → $32 |
| Aug-20-26 | Reiterated | Stifel Nicolaus | Buy | $28 → $29 |
| Jul-15-26 | Reiterated | Atlantic Equities | $52 → $42 | |
| Jun-26-26 | Reiterated | Stifel Nicolaus | Buy | $35 → $28 |
| Apr-09-26 | Reiterated | Cantor Fitzgerald | Neutral | $42 → $34 |
| Feb-13-26 | Reiterated | Stifel Nicolaus | Buy | $38 → $35 |
| Feb-13-26 | Reiterated | Piper Sandler | Overweight | $60 → $45 |
| Jan-29-26 | Reiterated | Stifel Nicolaus | Buy | $42 → $38 |
| Jan-14-26 | Reiterated | Cantor Fitzgerald | Neutral | $42 |
| Dec-19-25 | Reiterated | Piper Sandler | Overweight | $67 → $60 |
Latest News· Times ET
Sep-14-26
Sep-14-2605:39PM
Sep-10-26
Sep-10-2607:30AM
Sep-04-26
Aug-26-26
Aug-20-26
Aug-14-26
Aug-14-2601:12AM
Aug-13-26
Aug-13-2611:37PM
08:00AM
Aug-11-26
Aug-07-26
Aug-07-2611:26PM
10:41AM
Aug-05-26
10:05PM
Trupanion Q2 Earnings Call Highlightsmarketbeat.com
06:27PM
Company
Trupanion, Inc. provides monthly subscription-based medical insurance for canine and feline companions across the United States, Canada, Puerto Rico, and Australia. The company's operations are divided into two main categories: Subscription Business and Other Business, serving both pet owners and veterinary professionals. Founded in 2000, the Seattle, Washington-headquartered firm was previously known as Vetinsurance International, Inc., before adopting the Trupanion, Inc. name in 2013.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,521 | 1,439 | 1,286 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,179 | 1,029 | 1,107 | — | — | — | — | — | — | |
| Gross Profit | 342 | 410 | 179 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 98 | 162 | 64 | — | — | — | — | — | — | |
| Research and Development | 32 | 38 | 31 | — | — | — | — | — | — | |
| Other Operating Expense | 188 | 188 | 93 | — | — | — | — | — | — | |
| Operating Income | 24 | 22 | -10 | — | — | — | — | — | — | |
| Interest Expense | 11 | 14 | 14 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 13 | 14 | 14 | — | — | — | — | — | — | |
| Net Income Before Taxes | 26 | 22 | -10 | — | — | — | — | — | — | |
| Income Taxes | 4 | 3 | 0 | — | — | — | — | — | — | |
| Consolidated Net Income | 24 | 19 | -10 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 24 | 19 | -10 | — | — | — | — | — | — | |
| Net Income | 24 | 19 | -10 | — | — | — | — | — | — | |
| EPS (Recurring) | 0.53 | 0.45 | -0.23 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.53 | 0.45 | -0.23 | — | — | — | — | — | — | |
| EPS (Diluted) | 0.53 | 0.45 | -0.23 | — | — | — | — | — | — | |
| EBITDA | 52 | 52 | 21 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 48.36 | 83.04 | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.74 | 1.12 | 1.57 | — | — | — | — | — | — | |
| Gross Margin | 22.49 | 28.49 | 13.92 | — | — | — | — | — | — | |
| Operating Margin | 1.58 | 1.53 | -0.78 | — | — | — | — | — | — | |
| Net Margin | 1.58 | 1.32 | -0.78 | — | — | — | — | — | — | |
| Shares Outstanding | 44 | 43 | 42 | — | — | — | — | — | — | |
| Market Capitalization | 1,128 | 1,607 | 2,024 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Tooth Margaret | CEO | Sep 11 '26 | Sale | 25.00 | 1,000 | 25,000 | 185,952 | Sep 15 |
| GALLAGHER JOHN R | Chief Operating Officer | Aug 28 '26 | Sale | 29.70 | 3,604 | 107,039 | 33,742 | Sep 01 |
| Qureshi Fawwad | Chief Financial Officer | Aug 26 '26 | Sale | 30.01 | 6,111 | 183,391 | 4,230 | Aug 26 |
| POWELL BRADLEY S | Director | Aug 25 '26 | Option Exercise | 0.00 | 1,640 | 0 | 4,923 | Aug 26 |
| BEARMAN ASHER | Chief Legal Officer | Aug 25 '26 | Option Exercise | 0.00 | 125 | 0 | 74,053 | Aug 26 |
| WEINRAUCH STEVE | EVP, North Am & Vet Strategy | Aug 25 '26 | Option Exercise | 0.00 | 395 | 0 | 81,826 | Aug 26 |
| MCGIBNEY BRENNA | Chief Administration Officer | Aug 25 '26 | Option Exercise | 0.00 | 647 | 0 | 14,604 | Aug 26 |
| WHEELER SIMON | EVP, Trupanion International | Aug 25 '26 | Option Exercise | 0.00 | 322 | 0 | 25,488 | Aug 26 |
| Qureshi Fawwad | Chief Financial Officer | Aug 25 '26 | Option Exercise | 0.00 | 3,750 | 0 | 11,838 | Aug 26 |
| Tooth Margaret | CEO | Aug 25 '26 | Option Exercise | 0.00 | 1,250 | 0 | 187,443 | Aug 26 |
| Tooth Margaret | CEO | Aug 25 '26 | Sale | 31.84 | 491 | 15,633 | 186,952 | Aug 26 |
| GALLAGHER JOHN R | Chief Operating Officer | Aug 25 '26 | Option Exercise | 0.00 | 525 | 0 | 37,421 | Aug 26 |
| Tooth Margaret | CEO | Aug 22 '26 | Option Exercise | 0.00 | 17,792 | 0 | 189,414 | Aug 26 |
| GALLAGHER JOHN R | Chief Operating Officer | Aug 22 '26 | Option Exercise | 0.00 | 6,269 | 0 | 37,452 | Aug 26 |
| MCGIBNEY BRENNA | Chief Administration Officer | Aug 22 '26 | Option Exercise | 0.00 | 5,783 | 0 | 15,553 | Aug 26 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.